常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-2.42/-0.05
|
|
企业价值
1.66B
|
| 资产负债 |
|
每股账面净值
1.37
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
821.31M
|
|
每股收益
0.58
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2025/11/07 13:13 EST
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol. |

1.215 
